| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 12 5263-5269, Copyright © 1993 by American Association of Immunologists
ARTICLES |
E Lotzova, CA Savary and RE Champlin
Department of General Surgery, University of Texas, M. D. Anderson Cancer Center, Houston 77030.
We have found that fully functional CD56+CD3- NK cells can be generated from highly enriched populations of CD34+ human bone marrow progenitors in long term bone marrow culture (LTBMC) with IL-2. Strong lytic activity against K-562 cells was observed after 2 to 3 weeks of culture and coincided with the appearance of CD56+CD3- large granular lymphocytes, which comprised 55 to 84% of cells. In contrast, lymphocytes generated from CD34- bone marrow cells were predominantly CD56-CD3+ T cells. The phenotypic profile of NK cells generated in LTBMC differed from that of IL-2-cultured peripheral blood NK cells. Specifically, a lower percentage of LTBMC-derived NK cells coexpressed CD16, CD2, CD7, and CD8 Ag. NK cells generated in LTMBC proliferated actively, with an expansion index ranging from two- to 200-fold. Furthermore, NK cells were generated from the CD34+CD33- hematopoietic subset, which had been depleted of the myeloid-committed progenitors (CD34+CD33+). Generation of cytotoxic NK cells in LTBMC was dependent on the dose of IL-2; although CD56+CD3- NK cells were generated in LTBMC supplemented with a broad range of doses (10 to 10(3) U/ml) of IL- 2, the acquisition of full cytotoxic function required a high concentration of IL-2 (10(3) U/ml). These observations demonstrate the IL-2-driven differentiation of NK cells from early bone marrow progenitors and indicate that LTBMC may provide an excellent model for studies of NK cell lineage and differentiation in normal and pathologic conditions.
This article has been cited by other articles:
|
|
 |
|
  L. F. Porrata, M. A. Gertz, M. R. Litzow, M. Q. Lacy, A. Dispenzieri, D. J. Inwards, S. M. Ansell, I. N.M. Micallef, D. A. Gastineau, M. Elliott, et al. Early Lymphocyte Recovery Predicts Superior Survival after Autologous Hematopoietic Stem Cell Transplantation for Patients with Primary Systemic Amyloidosis Clin. Cancer Res., February 1, 2005; 11(3): 1210 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sconocchia, H. Fujiwara, K. Rezvani, K. Keyvanfar, F. El Ouriaghli, M. Grube, J. Melenhorst, N. Hensel, and A. J. Barrett G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte J. Leukoc. Biol., December 1, 2004; 76(6): 1214 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Miller and V. McCullar Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2 Blood, August 1, 2001; 98(3): 705 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Fehniger and M. A. Caligiuri Interleukin 15: biology and relevance to human disease Blood, January 1, 2001; 97(1): 14 - 32. [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Williams, J. Klem, I. J. Puzanov, P. V. Sivakumar, M. Bennett, and V. Kumar Differentiation of NK1.1+, Ly49+ NK Cells from flt3+ Multipotent Marrow Progenitor Cells J. Immunol., September 1, 1999; 163(5): 2648 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takahashi, I. Miura, K. Saitoh, and A. B. Miura Lineage Involvement of Stem Cells Bearing the Philadelphia Chromosome in Chronic Myeloid Leukemia in the Chronic Phase as Shown by a Combination of Fluorescence-Activated Cell Sorting and Fluorescence In Situ Hybridization Blood, December 15, 1998; 92(12): 4758 - 4763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yu, T. A. Fehniger, P. Fuchshuber, K. S. Thiel, E. Vivier, W. E. Carson, and M. A. Caligiuri Flt3 Ligand Promotes the Generation of a Distinct CD34+ Human Natural Killer Cell Progenitor That Responds to Interleukin-15 Blood, November 15, 1998; 92(10): 3647 - 3657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Shaw, A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic3 Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy J. Immunol., September 15, 1998; 161(6): 2817 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Miller, V. McCullar, and C. M. Verfaillie Ex Vivo Culture of CD34+/Lin-/DR- Cells in Stroma-Derived Soluble Factors, Interleukin-3, and Macrophage Inflammatory Protein-1alpha Maintains Not Only Myeloid But Also Lymphoid Progenitors in a Novel Switch Culture Assay Blood, June 15, 1998; 91(12): 4516 - 4522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Fehniger, W. E. Carson, E. Mrozek, and M. A. Caligiuri Stem Cell Factor Enhances Interleukin-2-Mediated Expansion of Murine Natural Killer Cells In Vivo Blood, November 1, 1997; 90(9): 3647 - 3653. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
